Nonprofit R&D DNDi is a not-for-profit international research and development organization focused on neglected diseases, presenting a clear path for grant-funded partnerships, philanthropic collaborations, and cost-sharing models with corporate partners seeking social impact.

Broad Disease Focus Active work across multiple neglected diseases and pediatric HIV, hepatitis C, and dengue offers sales opportunities for partner tools, services, or platforms that support multi-disease R&D, clinical trial management, or diagnostic development.

Open Collaboration Strong emphasis on partnerships (MSF, WHO, UNU, Pace University) and recent alliances with Sanofi, Scynexis, and DR C through Open Chagas programs indicate receptiveness to co-development, technology licensing, and capability-building engagements.

Clinical Trial Activity With over 20 clinical trials and more than 20 ongoing projects including new chemical entities, DNDi represents a steady demand for trial management software, data analytics, regulatory support, supply chain, and patient recruitment services.

Strategic Leadership Executive leadership changes and new board appointments signal a window for engaging at the strategic level on initiatives like scalable drug delivery, affordable manufacturing, and impact-driven funding models aligned with DNDi’s mission.